Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Digestive Diseases and Sciences
Published in: Digestive Diseases and Sciences 4/2007

01-04-2007 | Original Paper

The Canadian Celiac Health Survey

Authors: Ann Cranney, Marion Zarkadas, Ian D. Graham, J. Decker Butzner, Mohsin Rashid, Ralph Warren, Mavis Molloy, Shelley Case, Vernon Burrows, Connie Switzer

Published in: Digestive Diseases and Sciences | Issue 4/2007

Login to get access

Abstract

The purpose of this study was to characterize the diagnostic process, frequency of associated disorders, family history, and impact of a gluten-free diet in individuals with celiac disease. All members of the Canadian Celiac Association (n=5240) were surveyed with a questionnaire. Respondents included 2681 adults with biopsy-proven celiac disease. The mean age was 56 years. Most common presenting symptoms included abdominal pain (83%), diarrhea (76%), and weight loss (69%). The mean delay in diagnosis was 11.7 years. Diagnoses made prior to celiac disease included anemia (40%), stress (31%), and irritable bowel syndrome (29%). Osteoporosis was common. Prior to diagnosis, 27% of respondents consulted three or more doctors about their symptoms. Delays in diagnosis of celiac disease remain a problem. Associated medical conditions occur frequently. More accurate food labeling is needed. Improved awareness of celiac disease and greater use of serological screening tests may result in earlier diagnosis and reduced risk of associated conditions.
Literature
1.
Catassi C, Ratsch IM, Fabiani E, Rossini M, Bordicchia F, Candela F, Coppa GV, Giorgi PL (1994) Celiac disease in the year 2000; Exploring the iceberg. Lancet 343(8891):200–203PubMedCrossRef
2.
3.
4.
Bardella MT, Fredella C, Saladino V, Trovato C, Cesana BM, Quatrini M, Prampolini L (2005) Gluten intolerance: gender and age related differences in symptoms. Scand J Gastroenterol 40(1):15–19PubMedCrossRef
5.
NIH (2005) NIH Consensus Development Conference Statement on Celiac Disease, June 28–30, 2004. Gastroenterology 128(4; Suppl 1):S1–S9
6.
Tommasini A, Not T, Kiren V, Baldas V, Santon D, Trevisiol C, Berti I, Neri E, Gerarduzzi T, Bruno I, Lenhardt A, Zamuner E, Spano A, Crovella S, Martellossi S, Torre G, Sblattero D, Marzari R, Bradbury A, Tamburlini G, Ventura A (2004) Mass screening for celiac disease using antihuman transglutaminase antibody assay. Arch Dis Child 89(6):512–515PubMedCrossRef
7.
8.
Fasano A, Catassi C (2001) Current approaches to diagnosis and treatment of celiac disease: an evolving spectrum. Gastroenterology 120:636–651PubMedCrossRef
9.
Nelsen DA (2002) Gluten-sensitive enteropathy (celiac disease) more common than you think. Am Family Phys 66:2259–2266
10.
Lanzini A, Villanacci V, Apillan N, Lanzarotto F, Pirali F, Amato M, Indelicato A, Scarcella C, Donato F (2005) Epidemiological, clinical and histopathologic characteristics of celiac disease: results of a case-finding population-based program in an Italian community. Scand J Gastroenterol 40(8):950–957PubMedCrossRef
11.
Fasano A, Berti I, Gerdarduzzi T, Not T, Colletti RB, Drago S, Elitsur Y, Green PH, Guandalini S, Hill ID, Pietzak M, Ventura A, Thorpe M, Kryszak D, Fornaroli F, Wasserman SS, Murray JA, Horvath K (2003) Prevalence of celiac disease in at-risk and not-at-risk groups in the United States: a large multicenter study. Arch Intern Med 163(3):286–292PubMedCrossRef
12.
Baldas V, Tommasini A, Trevisiol C, Berti I, Fasano A, Sblattero D, Bradbury A, Marzari R, Barillari G, Ventura A, Not T (2000) Development of a novel rapid non-invasive screening test for celiac disease. Gut 47(5):628–631PubMedCrossRef
13.
Meyer D, Stavropoulos S, Diamond B, Shane E, Green PHR (2001) Osteoporosis in a North American adult population with celiac disease. Am J Gastroenterol 96:112–119PubMed
14.
Gasbarrini A, Torre ES, Trivellini C, De Carolis S, Caruso A, Gasbarrini G (2000) Recurrent spontaneous abortion and intrauterine fetal growth retardation as symptoms of coeliac disease. Lancet 356:399–400PubMedCrossRef
15.
Stazi AV, Mantovani A (2000) A risk factor for female fertility and pregnancy: celiac disease. Gynecol Endocrinol 14:454–463PubMedCrossRef
16.
Ludvigsson JF, Ludvigsson J (2001) Coeliac disease in the father affects the newborn. Gut 49:169–175PubMedCrossRef
17.
Holmes GKT, Prior P, Lane MR, Pope D, Allan RN (1989) Malignancy in coeliac disease—effect of a gluten free diet. Gut 30(3):333–338PubMed
18.
Green PHR, Goyal RK, Lo W, Fleischauer AT, Neugut AI (2001) Increased risk of malignancies in celiac disease (CD) patients in the US. Am J Gastroenterol 96(9):S106CrossRef
19.
Smedby KE, Akerman M, Hildebrand H, Glimelius B, Ekbom A, Askling J (2005) Malignant lymphomas in coeliac disease: evidence of increased risks for lymphoma types other than enteropathy type T cell lymphoma. Gut 54(1):54–59PubMedCrossRef
20.
De Vitis I, Ghirlanda G, Gasbarrini G (1996) Prevalence of coeliac disease in type I diabetes: a multicentre study. Acta Paediatr Suppl 412:56–57PubMed
21.
Cronin CC, Shanahan F (1997) Insulin-dependent diabetes mellitus and coeliac disease. Lancet 349:1096–1097PubMedCrossRef
22.
Gillett PM, Gillett HR, Israel DM, Metzger DL, Stewart L, Chanoine J-P, Freeman HJ (2001) High prevalence of celiac disease in patients with type I diabetes detected by antibodies to endomysium and tissue transglutaminase. Can J Gastroenterol 15(5):297–301PubMed
23.
Ventura A, Magazzu G, Greco L (1999) Duration of exposure to gluten and risk for autoimmune disorders in patients with celiac disease. Gastroenterology 117:297–303PubMedCrossRef
24.
Hakanen M, Luotola K, Salmi J, Laippala P, Kaukinen K, Collin P (2001) Clinical and subclinical autoimmune thryoid disease in adult celiac disease. Dig Dis Sci 46(12):2631–2635PubMedCrossRef
25.
Sategna Guidetti C, Grosso SB, Grosso S, Mengozzi G, Aimo G, Zaccaria T, Di Stefano M, Isaia GC (2000) The effects of 1-year gluten withdrawal on bone mass, bone metabolism and nutritional status in newly-diagnosed adult coeliac disease patients. Aliment Pharmacol Ther 14:35–43PubMedCrossRef
26.
Vazquez H, Mazure R, Gonzalez D, Flores D, Pedreira S, Niveloni S, Smecuol E, Mauriño E, Bai JC (2000) Risk of fractures in celiac disease patients: a cross-sectional, case-control study. Am J Gastroenterol 95(1):183–189CrossRef
27.
Ciacci C, Cirillo M, Auriemma G, Di Dato G, Sabbatini F, Mazzaca G (1996) Celiac disease and pregnancy outcome. Am J Gastroenterol 91(4):718–722PubMed
28.
Martinelli P, Troncone R, Paparo F, Torre P, Trapanese E, Fasano C, Lamberti A, Budillon G, Nardone G, Greco L (2000) Coeliac disease and unfavourable outcome of pregnancy. Gut 46(3):332–335PubMedCrossRef
29.
Corrao G, Corazza GR, Bagnardi V, Brusco G, Ciacci C, Cottone M, Sategna Guidetti C, Usai P, Cesari P, Pelli MA, Loperfido S, Volta U, Calabro A, Certo M, Club del Tenue Study Group (2001) Mortality in patients with celiac disease and their relatives: a cohort study. Lancet 358:356–361PubMedCrossRef
30.
Hervonen K, Vornanen M, Kautiainen H, Collin P, Reunala T (2005) Lymphoma in patients with dermatitis herpetiformis and their first-degree relatives. Br J Dermatol 152(1):82–86PubMedCrossRef
31.
Zarkadas M, Case S (2005) Celiac disease and the gluten-free diet—an overview. Top Clin Nutr 20:127–138
32.
Riddle DL, Lee MS, Stratford PW (2001) Use of SF-36 and SF-12 health status measures a quantitative comparison for groups versus individual patients. Med Care 30:867–878CrossRef
33.
Cranney A, Zarkadas M, Graham ID, Switzer C (2003) Canadian Celiac Health Survey–Ottawa Pilot. Biomed Central 3:8. http://​www.​biomedcentral.​com/​1471-230X/​3/​8
34.
Hopman WM, Towheed T, Anastassiades T, Tenenhouse A, Poliquin S, Berger C, Joseph L, Brown JP, Murray TM, Adachi JD, Hanley DA, Papadimitropoulos E (2000) Canadian normative data for the SF-36 health survey. CMAJ 163(3):265–271PubMed
35.
Green PHR, Stavropoulos SN, Panagi SG, Goldstein S, McMahon D, Absan H, Neugut A (2001) Characteristics of adult celiac disease in the USA: results of a national survey. Am J Gastroenterol 96(1):126–131PubMedCrossRef
36.
Davidson AGF, Campbell JA (1992) Celiac disease and dermatitis herpetiformis. Can Fam Phys 38:2604–2608
37.
Zipser RD, Patel S, Yahya KZ, Baisch DW, Monarch E (2003) Presentations of adult celiac disease in a nationwide patient support group. Dig Dis Sci 48:761–764PubMedCrossRef
38.
O'Leary C, Wieneke P, Buckley S., O'Regan P, Cronin CC, Quigley EM, Shanahan F (2002) Celiac disease and irritable bowel-type symptoms. Am J Gastroenterol 97(6):1463–1467PubMedCrossRef
39.
Sanders DS, Carter MJ, Hurlstone DP Pearce A, Ward AM, McAlindon ME, Lobo AJ (2001) Association of adult coeliac disease with irritable bowel syndrome: a case-control study in patients fulfilling ROME II criteria referred to secondary care. Lancet 358:1504–1508PubMedCrossRef
40.
41.
Logan RFA, Tucker G, Rifkind E, Heading RC, Ferguson A (1983) Changes in clinical features of celiac disease in adults in Edinburgh and the Lothians 1960–70. Br Med J 286:95–97CrossRef
42.
Murray JA, Watson T, Clearman B, Mitros F (2004) Effect of a gluten-free diet on gastrointestinal symptoms in celiac disease. Am J Clin Nutr 79(4):669–673PubMed
43.
Gabrielli M, Cremonini F, Fiore G, Addolorato G, Padalino C, Candelli M, De Leo ME, Santarelli L, Giacovazzo M, Pola P, Gasbarrini A (2003) Association between migraine and celiac disease: results from a preliminary case-control and therapeutic study. Am J Gastroenterol 98(3):625–629PubMedCrossRef
44.
Ojetti V, Nucera G, Migneco A, Gabrielli M, Lauritano C, Danese S, Assunta Zocco M, Nista EC, Cammarota G, De Lorenzo A, Gasbarrini G, Gasbarrini A (2005) High prevalence of celiac disease in patients with lactose intolerance. Digestion 71(2):106–110PubMedCrossRef
45.
Mitka M (2004) Higher profile needed for celiac disease, underdiagnosis fosters treatment delays says panel. JAMA 292:913–914PubMedCrossRef
46.
Hill ID, Dirks MH, Liptak GS, Colletti RB, Fasano A, Guandalini S, Hoffenberg EJ, Horvath K, Murray JA, Pivor M, Seidman EG, North American Society for Pediatric Gastroenterology, Hepatology and Nutrition (2005) Guideline for the diagnosis and treatment of celiac disease in children: recommendations of the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition. J Pediatr Gastroenterol Nutr 40(1):1–19PubMedCrossRef
47.
Midhagen G, Aberg A-K, Olcen P, Jarnerot G, Valdimarsson T, Dahlbom I, Hansson T, Strom M (2004) Antibody levels in adult patients with coeliac disease during gluten-free diet: a rapid initial decrease of clinical importance. J Int Med 256(6):519–524CrossRef
48.
Midhagen G, Hallert C (2003) High rate of gastrointestinal symptoms in celiac patients living on a gluten-free diet: controlled study. Am J Gastroenterol 98:2023–2026PubMedCrossRef
49.
Abdulkarim AS, Burgart LJ, See J, Murray JA (2002) Etiology of nonresponsive celiac disease; results of a systematic approach. Am J Gastroenterol 97:2016–2021PubMedCrossRef
50.
Case S (2005) The gluten-free diet: how to provide effective education and resources. Gastroenterology 128:S128–S134PubMedCrossRef
51.
Kemppainen TA, Kosma V-M, Janatuinen EK, Julkunen RJ, Pikkarainen PH, Uusitupa MI (1998) Nutritional status of newly diagnosed celiac disease patients before and after the institution of a celiac disease diet—association with the grade of mucosal villous atrophy. Am J Clin Nutr 67(3):482–487PubMed
52.
Annibale B, Severi C, Chistolini A, Giorgio Antonelli G, Edith Lahner E, Adriana Marcheggiano A, Carlo Iannoni C, Bruno Monarca B, Delle Fave G (2001) Efficacy of gluten-free diet alone on recovery from iron deficiency anemia in adult celiac patients. Am J Gastroenterol 96(1):132–137PubMedCrossRef
53.
Ferretti J, Mazure R, Tanoue P, Marino A, Cointry G, Vazquez H, Niveloni S, Pedreira S, Maurino E, Zanchetta J, Bai JC (2003) Analysis of the structure and strength of bones in celiac disease patients. Am J Gastroenterol 98(2):382–390PubMedCrossRef
54.
Bernstein CN, Leslie WD, LeBoff MS (2003) AGA technical review on osteoporosis in gastrointestinal diseases. Gastroenterology 124:795–841PubMedCrossRef
55.
Valdimarsson T, Toss G, Löfman O, Ström M (2000) Three years' follow-up of bone density in adult coeliac disease: significance of secondary hyperparathyroidism. Scand J Gastroenterol 35:274–280PubMedCrossRef
56.
Cranney A, Rostom A, Richmond S, Dube C, Saloogee N, Garritty C, Moher D, Sampson M, Zhang L, Yazdi F, Mamaladze V, Pan I, MacNeil J (2005) Consequences of testing for celiac disease. Gastroenterology 128(4):S109–S120PubMedCrossRef
57.
Gale J, Simmonds PD, Mead GM, Sweetenham JW, Wright DH (2000) Enteropathy-type intestinal T-cell lymphoma: clinical features and treatment of 31 patients in a single center. J Clin Oncol 18(4):795–803PubMed
58.
Askling J, Linet M, Gridley G, Halstensen TS, Ekstrom K, Ekbom A (2002) Cancer incidence in a population-based cohort of individuals hospitalized with celiac disease or dermatitis herpetiformis. Gastroenterology 123(5):1428–1435PubMedCrossRef
59.
Green PH, Fleischauer AT, Bhagat G, Goyal R; Jabri B; Neugut AI (2003) Risk of malignancy in patients with celiac disease. Am J Med 115(3):191–195PubMedCrossRef
60.
Norgard B, Fonager K, Sorensen HT, Olsen J (1999) Birth outcomes of women with celiac disease: a nationwide historical cohort study. Am J Gastroenterol 94:2435–2440PubMedCrossRef
61.
Ludvigsson JF, Montgomery SM, Ekbom A (2005) Celiac disease and risk of adverse fetal outome: a population-based cohort study. Gastroenterology 129:454–463PubMedCrossRef
62.
Greco L, Veneziano A, Di Donato L, Zampella C, Pecoraro M, Paladini D, Paparo F, Vollaro A, Martinelli P (2003) Undiagnosed coeliac disease does not appear to be associated with unfavorable outcome of pregnancy. Gut 53(1):149–151CrossRef
63.
Petaros P, Martelossi S, Tommasini A, Torre G, Caradonna M, Ventura A (2002) Prevalence of autoimmune disorders in relatives of patients with celiac disease. Dig Dis Sci 47:1427–1431PubMedCrossRef
64.
Hallert C, Granno C, Grant C, Hulten S, Midhagen G, Strom M, Svensson H, Valdimarsson T, Wickstrom T (1998) Quality of life of adult coeliac patients treated for 10 years. Scand J Gastoenterol 33(9):933–938CrossRef
65.
Hallert C, Granno C, Hulten G (2002) Living with celiac disease. Controlled study on the burden of illness. Scand J Gastroenterol 37:39–42
66.
Usai P, Minerba I, Marini B, Cossu R, Spada S, Carpiniello B, Cuomo R, Boy MF (2002) Case control study on health-related quality of life in adult coeliac disease. Dig Liver Dis 34(8):547–552PubMedCrossRef
67.
Lee A, Newman J (2003) Celiac disease: its impact on quality of life. J Am Diet Assoc 103:1533–1535PubMedCrossRef
Metadata
Title
The Canadian Celiac Health Survey
Authors
Ann Cranney
Marion Zarkadas
Ian D. Graham
J. Decker Butzner
Mohsin Rashid
Ralph Warren
Mavis Molloy
Shelley Case
Vernon Burrows
Connie Switzer
Publication date
01-04-2007
Published in
Digestive Diseases and Sciences / Issue 4/2007
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-006-9258-2

Other articles of this Issue 4/2007

Digestive Diseases and Sciences 4/2007 Go to the issue

Original Article

Total Parenteral Nutrition Leads to Alteration of Hepatocyte Cell Cycle Gene Expression and Proliferation in the Mouse

Original Article

Modafinil’s Use in Combating Interferon-Induced Fatigue

Letter to the Editor

Wilson’s Disease: What Lies Beneath

Review article

Cryoglobulinemia Related to Hepatitis C Virus Infection

Original Article

Inhibitory Activities and Attenuated Expressions of 5-LOX with Red Ginseng in Helicobacter pylori-Infected Gastric Epithelial Cells

Original Paper

Screening for Celiac Disease in Family Members: Is Follow-up Testing Necessary?
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits